Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/7d/9b/d3/7d9bd3f3-fa07-0f5b-2e8e-05a73f5c5c21/mza_11786603917402333547.jpg/600x600bb.jpg
Future of Drug Discovery
Murat Tunaboylu
17 episodes
1 week ago
The future of healthcare depends on a better-connected community. In the Future of Drug Discovery (FODD) series, we bring innovators together from academia and industry to forge new neural paths in our collective brain. Our hope is to catalyse interactions to form the next-generation treatments.
Show more...
Life Sciences
Science
RSS
All content for Future of Drug Discovery is the property of Murat Tunaboylu and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The future of healthcare depends on a better-connected community. In the Future of Drug Discovery (FODD) series, we bring innovators together from academia and industry to forge new neural paths in our collective brain. Our hope is to catalyse interactions to form the next-generation treatments.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/21629757/21629757-1697626032683-a03f8a0bf99fe.jpg
Ming 'Tommy' Tang - Unleashing the Power of Computational Biology (FODD #13)
Future of Drug Discovery
33 minutes 43 seconds
2 years ago
Ming 'Tommy' Tang - Unleashing the Power of Computational Biology (FODD #13)

In this talk, Murat speaks with Ming (Tommy) Tang, Director of Computational Biology at Immunitas Therapeutics, an immuno-oncology start-up developing novel therapeutics for patients with cancer. 


Tommy is a strong leader and communicator in the field of computational biology. He has dedicated his life's work to accelerating cancer research, with prominent expertise in analysing large-scale bulk sequencing data, single-cell and spatial transcriptomic data and epigenetic data.


Outside of his career at Immunitas, Tommy is a brilliant science communicator and teacher, with various educational streams, including Twitter, a blog, a GitHub repository, a YouTube channel, a newsletter, as well as authoring his own book, 'From Cell Line To Command Line'. He is passionate about teaching biologists the computational skills essential for modern science. 


You will learn:

  • How to stay ahead of the curve: developing the data analysis and bioinformatics skills essential to modern research.
  • How Immunitas is developing a discovery engine to aid the fight against cancer and the computational workflows behind it.
  • How to transition from a biologist to a computational biologist.
  • About the shift from academia to industry.
  • About Tommy's inspiring journey.


Things mentioned:

Link to all Tommy's resources: https://tommytang.bio.link/

  • Shanghai Jiao Tong University
  • University of Florida
  • MOOC Platforms: Udacity, Coursera, edX
  • Biostars
  • MD Anderson Cancer Center
  • Roel Verhaak
  • Cancer Genome Atlas Project
  • Harvard Faculty of Arts and Sciences
  • Shirley Liu's group at Dana Farber
  • Cancer Immunological Data Commons
  • Mount Sinai
  • Stanford
  • Tommy's Blog: https://divingintogeneticsandgenomics.com/
  • Immunitas's lead candidate: CD161 / IMT-009 / KORV1
  • Workflow management systems: SnakeMake, Nextflow...
  • Visgene
  • Matthew Berstein
  • PD-1
  • Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds.

Additional Materials: 

  • ⁠⁠⁠⁠⁠⁠⁠⁠⁠Watch the recording of the live event! ⁠https://youtu.be/CYa9rDFDaaI

First time hearing about Antiverse?

Antiverse is an artificial intelligence-driven techbio company that specialises in antibody design against difficult-to-drug targets, including G-protein coupled receptors (GPCRs) and ion channels. Headquartered in Cardiff, UK and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. With a main focus on establishing long-term partnerships, Antiverse has collaborated with two top 20 global pharmaceutical companies. In addition, they are developing a strong internal pipeline of antibodies against several challenging drug targets across various indications.

For more information, please visit ⁠⁠https://www.antiverse.io⁠⁠

Never miss a future event!

We'll notify you when there's a new event scheduled. Fill out ⁠⁠⁠this form⁠⁠⁠ to sign up for marketing communications from Antiverse. We post about upcoming events on LinkedIn and Twitter.

LinkedIn: ⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠

X: ⁠⁠⁠https://twitter.com/AntiverseHQ⁠

Future of Drug Discovery
The future of healthcare depends on a better-connected community. In the Future of Drug Discovery (FODD) series, we bring innovators together from academia and industry to forge new neural paths in our collective brain. Our hope is to catalyse interactions to form the next-generation treatments.